BRIEF

on BIOSYNEX (EPA:ALBIO)

BIOSYNEX secures majority support for its backup plan

Stock price chart of BIOSYNEX (EPA:ALBIO) showing fluctuations.

BIOSYNEX SA announces that 75.8% of creditors voted in favor of its safeguard plan, with a participation rate of 81.6%. Thus, the required majority of the affected classes of parties has supported the plan. The Strasbourg Judicial Court is now scheduled to rule on this plan on September 28, 2026.

Of the 14 classes involved, 11 approved the plan. Among these classes, 10 include priority creditors. If the plan is approved, it will apply to all parties, even dissenting ones.

CEO Larry Abensur expressed his gratitude to the creditors for their confidence and emphasized the importance of this step for the Group's recovery and future development.

R. P.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all BIOSYNEX news